Incidence of Sexually Transmitted Infections in Youth with HIV During Pre-COVID and COVID Era

被引:3
作者
Khan, Firdous [1 ]
Loerinc, Leah B. [2 ]
Scheel, Amy [2 ]
Gillespie, Scott E. [3 ]
Camacho-Gonzalez, Andres F. [4 ,5 ]
机构
[1] Augusta Univ, Med Coll Georgia, Augusta, GA USA
[2] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA USA
[3] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA USA
[4] Emory Univ, Childrens Healthcare Atlanta, Div Pediat Infect Dis, Dept Pediat,Sch Med, Atlanta, GA USA
[5] Grady Hlth Syst, Grady Infect Dis Program, Ponce Family & Youth Clin, Atlanta, GA USA
关键词
HIV; STIs; youth; coronavirus disease-19; ANTIRETROVIRAL THERAPY; IMPACT; BARRIERS; IMPLEMENTATION; SYPHILIS; ADOLESCENTS; PREVENTION; CARE;
D O I
10.1089/apc.2024.0060
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Adolescents and young adults (AYAs) living with HIV have high rates of co-sexually transmitted infections (STIs). During the coronavirus disease (COVID) pandemic, STI prevention strategies, including access to testing/treatment facilities, availability of health care workers, and condom availability, may have decreased. This study aimed to determine if differences in STI incidence for first infection and reinfection existed between the pre-COVID and COVID eras in a cohort of AYAs living with HIV in Atlanta, GA. Retrospective chart review was conducted for all patients between ages 13 and 24 at the Grady Ponce Clinic. Two eras were identified: a pre-COVID era (January 1, 2009-December31, 2019) and a COVID era (January 1, 2020-June 30, 2021). STIs recorded included gonorrhea, chlamydia, human papillomavirus, syphilis, trichomonas, herpes simplex virus, lymphogranuloma venereum, hepatitis C, bacterial vaginosis, and chancroid. First and recurrent incidence rates for any STIs were reported. Our sample included 766 sexually active AYAs with HIV. A total of 721 patients were included in the pre-COVID era and 583 (80.9%) had at least one STI. A total of 337 patients were included in the COVID era, and 158 had at least one STI (46.9%). The overall first STI incidence rate increased from 42.47 to 58.67 per 100 person-years (PY) and the recurrent STI incidence rate increased from 121.50 to 169.85 per 100 PY from the pre-COVID to the COVID era (p < 0.001). Our study demonstrated significantly higher incidence rates of first and recurrent STIs in AYAs living with HIV in the COVID era. We urge continuation of existing STI prevention programs to avoid secondary clinical and economic adverse effects of increased infections.
引用
收藏
页码:252 / 258
页数:7
相关论文
共 92 条
  • [51] Johnston C., Here's Why
  • [52] Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County
    Jolayemi, Oluwadamilola
    Bogart, Laura M.
    Storholm, Erik D.
    Goodman-Meza, David
    Rosenberg-Carlson, Elena
    Cohen, Rebecca
    Kao, Uyen
    Shoptaw, Steve
    Landovitz, Raphael J.
    [J]. PLOS ONE, 2022, 17 (02):
  • [53] Forget about forgetting: structural barriers and severe non-adherence to antiretroviral therapy
    Kalichman, Seth C.
    Kalichman, Moira O.
    Cherry, Chauncey
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2017, 29 (04): : 418 - 422
  • [54] Kanazawa JT, 2021, AIDS RES HUM RETROV, V37, P75, DOI [10.1089/aid.2020.0126, 10.1089/AID.2020.0126]
  • [55] Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir plus rilpivirine (LATTE-2) in the United States and Spain
    Kerrigan, Deanna
    Mantsios, Andrea
    Gorgolas, Miguel
    Montes, Maria-Luisa
    Pulido, Federico
    Brinson, Cynthia
    deVente, Jerome
    Richmond, Gary J.
    Beckmam, Sarah W.
    Hammond, Paige
    Margolis, David
    Murray, Miranda
    [J]. PLOS ONE, 2018, 13 (01):
  • [56] Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case series
    Kilcrease, Christin
    Yusuf, Hasiya
    Park, Joan
    Powell, Aaron
    Rn, Leon James
    Rn, Jacob Oates
    Lmsw, Brittany Davis
    Weld, Ethel D.
    Dooley, Kelly E.
    Arrington-Sanders, Renata
    Agwu, Allison L.
    [J]. AIDS RESEARCH AND THERAPY, 2022, 19 (01)
  • [57] Sexual Transmission Risk Behavior of Adolescents With HIV Acquired Perinatally or Through Risky Behaviors
    Koenig, Linda J.
    Pals, Sherri L.
    Chandwani, Sulachni
    Hodge, Krystal
    Abramowitz, Susan
    Barnes, William
    D'Angelo, Lawrence
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 55 (03) : 380 - 390
  • [58] Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
    Koester K.A.
    Colasanti J.A.
    McNulty M.C.
    Dance K.
    Erguera X.A.
    Tsuzuki M.D.
    Johnson M.O.
    Sauceda J.A.
    Montgomery E.
    Schneider J.
    Christopoulos K.A.
    [J]. Implementation Science Communications, 4 (1):
  • [59] COVID-19 lockdowns throughout the world
    Koh, David
    [J]. OCCUPATIONAL MEDICINE-OXFORD, 2020, 70 (05): : 322 - 322
  • [60] Impact of COVID-19 on Sexually Transmitted Infection and HIV Screening at an Urban Safety-Net Hospital
    Lescure, Tyler N.
    Stewart, Jessica
    Sperring, Heather
    Ruiz-Mercado, Glorimar
    Taylor, Jessica L.
    [J]. AIDS PATIENT CARE AND STDS, 2023, 37 (04) : 199 - 204